FDA approval | International Myeloma Foundation

FDA stamp of approval

Week in Review

February 26

FDA Reverses ODAC Vote and Approves Panobinostat (Farydak®) for Relapsed Myeloma

FDA approval stamp

Week in Review

February 19

Revlimid Receives Frontline Approval in the US

Image of a globe focusing on Southeast Asia

Week in Review

January 29

IMF’s Asian Myeloma Network Succeeds in Providing Access to Pomalidomide in Asia

Medication spills out of a prescription container

Week in Review

January 14

Where Do New Drugs Come From?

Audience at an event

Week in Review

July 23

US Myeloma Flow Workshop in New York

Female doctor talking to senior female patient

Week in Review

October 9

Matching Resources with Stratified Recommendations for Myeloma Care

Bronze statue in front of law books

Week in Review

October 7

Pomalidomide Update

chocolate chip cookies.

Week in Review

July 17

Can Cookies Cause Myeloma?

Books on Regulatons

Week in Review

August 4

Early Access to Carfilzomib for Eligible Patients

Subscribe to FDA approval

Give Where Most Needed